CSL Limited
CSL
Helyezés a részvények között
#363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Részvényárfolyam
$139.04
Piaci kapitalizáció
$66.72B
Változás (1 nap)
1.05%
Változás (1 év)
-1.97%
Ország
AU
Kereskedés CSL Limited (CSL)
Kategória
Healthcare
EPS CSL Limited (CSL) részvényre
EPS June 2026 dátummal, TTM: $-5.29
CSL Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $-5.29. 2024 végén a vállalat EPS mutatója $5.47 volt, növekedés a 2023 év EPS értékéhez, amely $4.55 volt.
CSL Limited EPS története 2000 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $-5.29 | -185.32% |
| 2025 | $6.20 | 13.35% |
| 2024 | $5.47 | 20.22% |
| 2023 | $4.55 | -31.37% |
| 2022 | $6.63 | 26.05% |
| 2021 | $5.26 | 13.61% |
| 2020 | $4.63 | 9.20% |
| 2019 | $4.24 | 50.89% |
| 2018 | $2.81 | -4.42% |
| 2017 | $2.94 | 9.29% |
| 2016 | $2.69 | -7.88% |
| 2015 | $2.92 | 8.15% |
| 2014 | $2.70 | 21.09% |
| 2013 | $2.23 | 12.45% |
| 2012 | $1.98 | -0.58% |
| 2011 | $1.99 | 49.05% |
| 2010 | $1.34 | 6.70% |
| 2009 | $1.25 | 7.16% |
| 2008 | $1.17 | 64.09% |
| 2007 | $0.71 | 500.34% |
| 2006 | $0.12 | -78.01% |
| 2005 | $0.54 | 168.22% |
| 2004 | $0.20 | 202.40% |
| 2003 | $0.07 | -21.18% |
| 2002 | $0.08 | -5.06% |
| 2001 | $0.09 | 83.13% |
| 2000 | $0.05 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| $17.32 | -427.41% |
US
|
|
| $-7.98 | 50.85% |
US
|
|
| - | - |
CH
|
|
| $27.74 | -624.39% |
NL
|
|
| $13.70 | -358.98% |
BE
|
